Perflutren Protein Type A and Zanamivir Inhalation, oral/nebulization
Determining the interaction of Perflutren Protein Type A and Zanamivir Inhalation, oral/nebulization and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
Generic Name: zanamivir
Brand name: Relenza
Synonyms: Zanamivir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Perflutren Protein Type A-Zanosar
- Perflutren Protein Type A-Zantac
- Perflutren Protein Type A-Zantac (Ranitidine Injection)
- Perflutren Protein Type A-Zantac (Ranitidine Syrup)
- Perflutren Protein Type A-Zantac (Ranitidine Tablets and Capsules)
- Perflutren Protein Type A-Zantac Cool Mint
- Zanamivir Inhalation, oral/nebulization-Perflutren protein type a microsphere Intravenous
- Zanamivir Inhalation, oral/nebulization-Perforomist
- Zanamivir Inhalation, oral/nebulization-Perforomist, Symbicort
- Zanamivir Inhalation, oral/nebulization-Pergolide
- Zanamivir Inhalation, oral/nebulization-Pergonal
- Zanamivir Inhalation, oral/nebulization-Peri-Colace